Logo 1 Logo 2

Clinical Trial Details

Trial ID: L7350
Source ID: NCT00333151
Associated Drug: Liraglutide
Title: Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Acronym: LEAD-4
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: liraglutide|DRUG: rosiglitazone|DRUG: metformin
Outcome Measures: Primary: HbA1c, after 26 weeks of treatment | Secondary: body weight|Safety and tolerability|Glycaemic control
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 576
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2006-05
Completion Date: 2007-08
Results First Posted:
Last Update Posted: 2017-01-25
Locations: Novo Nordisk Investigational Site, Goodyear, Arizona, 85395, United States|Novo Nordisk Investigational Site, Colton, California, 92324, United States|Novo Nordisk Investigational Site, Concord, California, 94520, United States|Novo Nordisk Investigational Site, Escondido, California, 92025, United States|Novo Nordisk Investigational Site, La Jolla, California, 92037, United States|Novo Nordisk Investigational Site, Long Beach, California, 90822, United States|Novo Nordisk Investigational Site, Los Angeles, California, 90024, United States|Novo Nordisk Investigational Site, Los Angeles, California, 90057, United States|Novo Nordisk Investigational Site, Mission Viejo, California, 92691, United States|Novo Nordisk Investigational Site, Orange, California, 92869, United States|Novo Nordisk Investigational Site, Santa Ana, California, 92705, United States|Novo Nordisk Investigational Site, Santa Barbara, California, 93105, United States|Novo Nordisk Investigational Site, Spring Valley, California, 91978, United States|Novo Nordisk Investigational Site, New Britain, Connecticut, 06050, United States|Novo Nordisk Investigational Site, Washington, District of Columbia, 20010, United States|Novo Nordisk Investigational Site, Fort Myers, Florida, 33907, United States|Novo Nordisk Investigational Site, Jacksonville, Florida, 32204, United States|Novo Nordisk Investigational Site, Lake Mary, Florida, 32746, United States|Novo Nordisk Investigational Site, Plantation, Florida, 33324, United States|Novo Nordisk Investigational Site, Athens, Georgia, 30606, United States|Novo Nordisk Investigational Site, Atlanta, Georgia, 30032, United States|Novo Nordisk Investigational Site, Atlanta, Georgia, 30034, United States|Novo Nordisk Investigational Site, Atlanta, Georgia, 30318, United States|Novo Nordisk Investigational Site, Powder Springs, Georgia, 30127, United States|Novo Nordisk Investigational Site, Idaho Falls, Idaho, 83404-7596, United States|Novo Nordisk Investigational Site, Peoria, Illinois, 61615, United States|Novo Nordisk Investigational Site, New Albany, Indiana, 47150, United States|Novo Nordisk Investigational Site, Des Moines, Iowa, 50314, United States|Novo Nordisk Investigational Site, Topeka, Kansas, 66606, United States|Novo Nordisk Investigational Site, Lexington, Kentucky, 40503, United States|Novo Nordisk Investigational Site, Baton Rouge, Louisiana, 70808, United States|Novo Nordisk Investigational Site, New Orleans, Louisiana, 70121, United States|Novo Nordisk Investigational Site, Hyattsville, Maryland, 20782, United States|Novo Nordisk Investigational Site, Tupelo, Mississippi, 38801, United States|Novo Nordisk Investigational Site, St. Louis, Missouri, 63110, United States|Novo Nordisk Investigational Site, Reno, Nevada, 89502, United States|Novo Nordisk Investigational Site, Berlin, New Jersey, 08009, United States|Novo Nordisk Investigational Site, Plainsboro, New Jersey, 08536, United States|Novo Nordisk Investigational Site, Albany, New York, 12206, United States|Novo Nordisk Investigational Site, Brooklyn, New York, 11203, United States|Novo Nordisk Investigational Site, Northport, New York, 11768, United States|Novo Nordisk Investigational Site, Rochester, New York, 14621, United States|Novo Nordisk Investigational Site, Asheville, North Carolina, 28803, United States|Novo Nordisk Investigational Site, Chapel Hill, North Carolina, 27599-7172, United States|Novo Nordisk Investigational Site, Durham, North Carolina, 27710, United States|Novo Nordisk Investigational Site, Greenville, North Carolina, 27834, United States|Novo Nordisk Investigational Site, Cincinnati, Ohio, 45245, United States|Novo Nordisk Investigational Site, Cleveland, Ohio, 44195, United States|Novo Nordisk Investigational Site, Columbus, Ohio, 43203, United States|Novo Nordisk Investigational Site, Columbus, Ohio, 43212, United States|Novo Nordisk Investigational Site, Dayton, Ohio, 45406, United States|Novo Nordisk Investigational Site, Kettering, Ohio, 45429, United States|Novo Nordisk Investigational Site, Mentor, Ohio, 44060, United States|Novo Nordisk Investigational Site, Duncan, South Carolina, 29334, United States|Novo Nordisk Investigational Site, Chattanooga, Tennessee, 37404, United States|Novo Nordisk Investigational Site, Arlington, Texas, 76014, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75230, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75231, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75246, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75390-8858, United States|Novo Nordisk Investigational Site, Houston, Texas, 77025, United States|Novo Nordisk Investigational Site, Houston, Texas, 77030, United States|Novo Nordisk Investigational Site, Lubbock, Texas, 79430-8183, United States|Novo Nordisk Investigational Site, Midland, Texas, 79707, United States|Novo Nordisk Investigational Site, San Antonio, Texas, 78209, United States|Novo Nordisk Investigational Site, San Antonio, Texas, 78229, United States|Novo Nordisk Investigational Site, Salt Lake City, Utah, 84102, United States|Novo Nordisk Investigational Site, Newport News, Virginia, 23606, United States|Novo Nordisk Investigational Site, Richmond, Virginia, 23294, United States|Novo Nordisk Investigational Site, Spokane, Washington, 99218, United States|Novo Nordisk Investigational Site, Milwaukee, Wisconsin, 53209, United States|Novo Nordisk Investigational Site, Calgary, Alberta, T2H 2G4, Canada|Novo Nordisk Investigational Site, Edmonton, Alberta, T5J 3N4, Canada|Novo Nordisk Investigational Site, Winnipeg, Manitoba, R3E 3P4, Canada|Novo Nordisk Investigational Site, Halifax, Nova Scotia, B3H 1V7, Canada|Novo Nordisk Investigational Site, London, Ontario, N6A 4V2, Canada|Novo Nordisk Investigational Site, Ottawa, Ontario, K1N 6N5, Canada|Novo Nordisk Investigational Site, Toronto, Ontario, M5C 2T2, Canada|Novo Nordisk Investigational Site, Laval, Quebec, H7T 2P5, Canada|Novo Nordisk Investigational Site, Gatineau, J8T 8M1, Canada|Novo Nordisk Investigational Site, Mississauga, L5M 2V8, Canada|Novo Nordisk Investigational Site, Montreal, H2W 1R7, Canada|Novo Nordisk Investigational Site, Montreal, H3A 1A1, Canada|Novo Nordisk Investigational Site, Quebec, G1V 4G2, Canada|Novo Nordisk Investigational Site, Red Deer, T4N 6V7, Canada|Novo Nordisk Investigational Site, St John's, A1B 3V6, Canada|Novo Nordisk Investigational Site, Toronto, M5G 1X5, Canada|Novo Nordisk Investigational Site, Vancouver, V5Z 1C6, Canada|Novo Nordisk Investigational Site, Windsor, N8W 3K2, Canada
URL: https://clinicaltrials.gov/show/NCT00333151

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D116 Rosiglitazone small molecule DB00412 Details
D089 Metformin small molecule DB00331 Details